Buckley Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Buckley Wealth Management's GILD Position: Q4 2022 in Review
Buckley Wealth Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 56,067 shares — an estimated $3.46M sold.
Buckley Wealth Management first reported a position in GILD in Q4 2017 and held it in 20 quarters. The position peaked at $4.77M in Q4 2021. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- Buckley Wealth Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
- Buckley Wealth Management sold 56,067 Gilead Sciences shares in Q4 2022, an estimated $3.46M.
- Buckley Wealth Management first reported a position in Gilead Sciences in Q4 2017 and held it in 20 quarters.
- Buckley Wealth Management's Gilead Sciences position peaked at $4.77M in Q4 2021.
- 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on Buckley Wealth Management's 13F filing for Q4 2022, filed 10 Feb 2023.